Nu-Med Plus, Inc.

NUMD OTC SEC CIK 1543637
Follow Nu-Med Plus Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $0
Net income $19.7K +268.6% vs same quarter last year
EPS, diluted $0.00
Operating cash flow $1.1K +174.5% vs same quarter last year
Revenue by quarter
$0
$0
$0
$0
Q1 25 Q2 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$10M−$5M$0$5M$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$56.2K
FY24-−$68.3K
FY23-−$125.5K
FY22-−$130.2K
FY21-−$830.1K
FY20$0−$2M
FY19$0−$1M
FY18$0−$1.2M
FY17$0$3.6M
FY16$0$9.7M
FY15$0−$8.9M
FY14$0−$1.2M
FY13$0−$332.3K
FY12$0−$262.7K
FY11--
Free cash flowOperating cash flow minus capital expenditure
−$600K−$400K−$200K$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22-
FY21-
FY20-
FY19−$567.3K
FY18−$472.6K
FY17−$430.5K
FY16-
FY15−$182.9K
FY14−$159.4K
FY13−$169.4K
FY12−$123K
FY11-

News

No stories filed under Nu-Med Plus yet - coverage appears here as the news feed clusters it.